Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 241โ€“255 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-6263
COG6 Gene Glycosylation Disorder Type 3 Genetic Test

This genetic test identifies pathogenic variants in the COG6 gene, which are responsible for Congenital Disorder of Glycosylation Type 3.

Whole Blood (EDTA), FTA Card, Extracted DNA 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COG6 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected Congenital Disorder of Glycosylation Type 3", "Multisystem involvement with metabolic abnormalities", "Family history of CDG Type 3"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94146-5 ICD-10: E77.8, Z82.79, Z13.228
Clinical summary
This genetic test identifies pathogenic variants in the COG6 gene, which are responsible for Congenital Disorder of Glycosylation Type 3.
TEST-5075
COL11A2 Gene Fibrochondrogenesis Type 2 Genetic Test

This genetic test evaluates the COL11A2 gene for pathogenic variants associated with Fibrochondrogenesis Type 2.

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in COL11A2 gene", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variants (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Prenatal diagnosis of Fibrochondrogenesis Type 2", "Carrier screening for Fibrochondrogenesis Type 2", "Familial risk counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21698-3 ICD-10: Q77.5
Clinical summary
This genetic test evaluates the COL11A2 gene for pathogenic variants associated with Fibrochondrogenesis Type 2.
TEST-3925
COL12A1 Gene Bethlem Myopathy Type 2 Genetic Test

This test evaluates the COL12A1 gene for pathogenic variants associated with Bethlem myopathy type 2.

Whole Blood, Buccal Swab, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL12A1 gene", "Full gene coverage including intron-exon boundaries"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet instructions"]
Indications
["Suspected diagnosis of Bethlem myopathy type 2", "Family history of collagen VI-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92807-5 ICD-10: G71.0
Clinical summary
This test evaluates the COL12A1 gene for pathogenic variants associated with Bethlem myopathy type 2.
TEST-5936
COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test

This genetic test detects pathogenic variants in the COL12A1 gene associated with Ullrich congenital muscular dystrophy type 2.

Peripheral whole blood, extracted DNA, or FTA card 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL12A1 gene"]
Parameters
[]
Preparation
["Genetic counselling is mandatory prior to testing"]
Indications
["Individuals presenting with clinical features suggestive of Ullrich congenital muscular dystrophy type 2", "Carrier testing", "Reproductive planning in families with known COL12A1 mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 74834-3 ICD-10: G71.0
Clinical summary
This genetic test detects pathogenic variants in the COL12A1 gene associated with Ullrich congenital muscular dystrophy type 2.
TEST-5154
COL17A1 Gene Epidermolysis Bullosa, Junctional Genetic Test

This test evaluates the COL17A1 gene for mutations associated with junctional epidermolysis bullosa (JEB). It uses Next-Generation Sequencing (NGS) to provide comprehensive coverag...

Peripheral Whole Blood (EDTA) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COL17A1 gene sequence", "Pathogenic variants in COL17A1"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions unless advised by physician"]
Indications
["Clinical suspicion of junctional epidermolysis bullosa", "Confirmed family history of COL17A1-related disorders", "Need for definitive molecular diagnosis", "Guidance for wound care and nutritional management", "Family genetic counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82160-5 ICD-10: Q81.1
Clinical summary
This test evaluates the COL17A1 gene for mutations associated with junctional epidermolysis bullosa (JEB). It uses Next-Generation Sequencing (NGS) to provide comprehensive coverage of the gene.
TEST-4741
COL2A1 Gene Osteoarthritis with Mild Chondrodysplasia Genetic Test

This test evaluates the COL2A1 gene for pathogenic variants associated with early-onset osteoarthritis and mild chondrodysplasia.

Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot) 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL2A1 gene", "Copy Number Variants (CNVs) in the COL2A1 gene"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session", "Provide detailed clinical history and family history"]
Indications
["Diagnosis of early-onset osteoarthritis with mild chondrodysplasia", "Family risk assessment for COL2A1-related disorders", "Differentiation from other forms of arthritis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101454-2 ICD-10: M19.90
Clinical summary
This test evaluates the COL2A1 gene for pathogenic variants associated with early-onset osteoarthritis and mild chondrodysplasia.
TEST-2466
COL2A1 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test

This test identifies pathogenic variants within the COL2A1 gene associated with otospondylomegaepiphyseal dysplasia (OSMED) and related type II collagenopathies.

Whole blood (2โ€“3 mL EDTA) or dried blood spot (FTA card) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL2A1 gene"]
Parameters
[]
Preparation
["No fasting required", "No medication changes needed", "Inform phlebotomist if on anticoagulants"]
Indications
["Suspected otospondylomegaepiphyseal dysplasia (OSMED)", "Suspected Stickler syndrome", "Family history of type II collagenopathies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81305-2 ICD-10: Q77.8
Clinical summary
This test identifies pathogenic variants within the COL2A1 gene associated with otospondylomegaepiphyseal dysplasia (OSMED) and related type II collagenopathies.
TEST-2276
COL2A1 Gene Spondyloperipheral Dysplasia Genetic Test

This genetic test identifies pathogenic variants within the COL2A1 gene, which are associated with spondyloperipheral dysplasia.

Whole Blood, Extracted DNA, or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL2A1 gene"]
Parameters
[]
Preparation
["No special preparation required", "A prior genetic counselling session to draw a pedigree chart is mandatory"]
Indications
["Suspected spondyloperipheral dysplasia", "Differential diagnosis of skeletal dysplasias", "Family planning for inherited conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81257-1 ICD-10: Q77.8
Clinical summary
This genetic test identifies pathogenic variants within the COL2A1 gene, which are associated with spondyloperipheral dysplasia.
TEST-2402
COL4A1 Gene Porencephaly, Familial Genetic Test

This test evaluates the COL4A1 gene for pathogenic variants associated with familial porencephaly and cerebral small vessel disease.

Peripheral Whole Blood, FTA Card, or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL4A1 gene", "Point mutations", "Small indels", "Exon-level copy number variants"]
Parameters
[]
Preparation
[]
Indications
["Individuals with personal or family history of early-onset stroke", "Individuals with personal or family history of brain cysts", "Individuals with personal or family history of developmental delay", "Suspected familial porencephaly", "Cerebral small vessel disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49990-2 ICD-10: Q04.6
Clinical summary
This test evaluates the COL4A1 gene for pathogenic variants associated with familial porencephaly and cerebral small vessel disease.
TEST-5170
COL5A1 Gene Ehlers-Danlos Syndrome Type 1/2 Genetic Test

This test identifies pathogenic variants in the COL5A1 gene to confirm a molecular diagnosis of Classical Ehlers-Danlos Syndrome (Type 1/2).

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL5A1 gene", "Copy Number Variations (CNV) in COL5A1"]
Parameters
[]
Preparation
["No special preparation such as fasting is required.", "Complete a comprehensive clinical history form.", "Participate in a mandatory genetic counselling session for familial pedigree charting."]
Indications
["Clinical suspicion of Classical Ehlers-Danlos Syndrome (cEDS)", "Confirmation of cEDS diagnosis", "Genetic counseling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90207-0 ICD-10: Q79.6
Clinical summary
This test identifies pathogenic variants in the COL5A1 gene to confirm a molecular diagnosis of Classical Ehlers-Danlos Syndrome (Type 1/2).
TEST-4261
COL6A3 Gene DYT27 Genetic Test

This test evaluates the entire coding region of the COL6A3 gene for pathogenic variants associated with autosomal dominant dystonia type 27 (DYT27).

Whole Blood (EDTA), Extracted DNA (โ‰ฅ1 ยตg), or FTA Card Blood Spot 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL6A3 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected autosomal dominant dystonia type 27 (DYT27)", "Inconclusive prior neurological evaluations for dystonia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79371-8 ICD-10: G24.1
Clinical summary
This test evaluates the entire coding region of the COL6A3 gene for pathogenic variants associated with autosomal dominant dystonia type 27 (DYT27).
TEST-442
Combined Whole Exome Sequencing (WES) and Chromosomal Microarray (CMA) Test

This test evaluates the entire protein-coding region of the genome (exome) and chromosomal copy number variations (CNVs) simultaneously.

Peripheral whole blood (EDTA) โ€“ 3โ€“5 mL 14โ€“21 calendar days 5,000.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants", "Indels", "Copy Number Variations (CNVs)", "Regions of Homozygosity (AOH)"]
Parameters
[{"name": "Methodology", "reference_range": "NGS (Illumina NovaSeq) Exome Capture + Affymetrix CytoScan HD Array"}, {"name": "Resolution", "reference_range": "Single-nucleotide variants, indels, CNVs โ‰ฅ25 kb, AOH regions"}, {"name": "Diagnostic Yield (Neurodevelopmental)", "reference_range": "~45โ€“50%"}]
Preparation
["No fasting required", "Inform nursing team if taking blood-thinning medications", "Inform genetic counsellor of recent blood transfusions or allogeneic bone marrow transplants"]
Indications
["Paediatric neurodevelopmental delay", "Dysmorphic syndromes", "Hereditary cancer predisposition", "Global developmental delay", "Multiple congenital anomalies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-2 ICD-10: Z13.79, Q99.9, Z15.09
Clinical summary
This test evaluates the entire protein-coding region of the genome (exome) and chromosomal copy number variations (CNVs) simultaneously.
TEST-5132
COMP Gene Epiphyseal Dysplasia, Multiple, Type 1 Genetic Test

This genetic test identifies pathogenic variants in the COMP gene associated with Multiple Epiphyseal Dysplasia Type 1 (MED1).

Whole blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COMP gene coding region", "Pathogenic variants"]
Parameters
[]
Preparation
[]
Indications
["Symptomatic patients", "At-risk family members", "Proactive genetic screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21567-2 ICD-10: Q77.7
Clinical summary
This genetic test identifies pathogenic variants in the COMP gene associated with Multiple Epiphyseal Dysplasia Type 1 (MED1).
TEST-4641
COMP Gene Pseudoachondroplasia Genetic Test

This test evaluates the entire COMP gene for mutations associated with pseudoachondroplasia.

Peripheral Whole Blood 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COMP gene mutations", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations"]
Parameters
[]
Preparation
[]
Indications
["Diagnostic confirmation of pseudoachondroplasia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21635-2 ICD-10: Q77.3
Clinical summary
This test evaluates the entire COMP gene for mutations associated with pseudoachondroplasia.
TEST-702
Complete Body Panel Test

This test evaluates metabolic, hepatic, renal, hematologic, and urinary health through a comprehensive panel of blood and urine tests.

Whole blood, serum, plasma, urine 3 days (sample by 9 AM) 650.00 AED
View
View test specifications and preparation
What it measures
["Fasting glucose", "HbA1c (if ordered)", "Lipid panel", "Liver enzymes (ALT, AST, ALP, GGT)", "Kidney markers (creatinine, BUN, eGFR)", "Complete blood count (CBC) with differential", "Urinalysis (dipstick and microscopic)"]
Parameters
[{"name": "Fasting Glucose", "reference_range": null}, {"name": "HbA1c", "reference_range": null}, {"name": "Lipid Panel", "reference_range": null}, {"name": "ALT", "reference_range": null}, {"name": "AST", "reference_range": null}, {"name": "ALP", "reference_range": null}, {"name": "GGT", "reference_range": null}, {"name": "Creatinine", "reference_range": null}, {"name": "BUN", "reference_range": null}, {"name": "eGFR", "reference_range": null}, {"name": "Complete Blood Count (CBC) with differential", "reference_range": null}, {"name": "Urinalysis (dipstick and microscopic)", "reference_range": null}]
Preparation
["Fast for 12 hours overnight, drinking only water.", "Avoid alcohol and strenuous exercise for 24 hours prior.", "Continue prescribed medications unless instructed otherwise."]
Indications
["Preventive care", "Baseline health assessment", "Screening for metabolic disorders", "Screening for kidney disease", "Screening for liver disorders", "Screening for lipid disorders", "Screening for anemia", "Screening for infection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 24377-4 ICD-10: Z00.00
Clinical summary
This test evaluates metabolic, hepatic, renal, hematologic, and urinary health through a comprehensive panel of blood and urine tests.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area